GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,065,000 | +0.5% | 24,477 | +0.6% | 0.05% | +15.0% |
| Q1 2022 | $1,060,000 | +1091.0% | 24,327 | +1108.5% | 0.04% | +1233.3% |
| Q4 2021 | $89,000 | 0.0% | 2,013 | -13.2% | 0.00% | -25.0% |
| Q3 2021 | $89,000 | +36.9% | 2,318 | +41.5% | 0.00% | +33.3% |
| Q2 2021 | $65,000 | +12.1% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | -3.3% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $60,000 | -3.2% | 1,638 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $62,000 | -7.5% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $67,000 | -4.3% | 1,638 | -10.9% | 0.00% | -20.0% |
| Q1 2020 | $70,000 | -9.1% | 1,838 | +12.2% | 0.01% | 0.0% |
| Q4 2019 | $77,000 | +10.0% | 1,638 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $70,000 | +6.1% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $66,000 | -2.9% | 1,638 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $68,000 | +7.9% | 1,638 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $63,000 | -7.4% | 1,638 | -3.9% | 0.01% | 0.0% |
| Q3 2018 | $68,000 | +3.0% | 1,705 | +4.1% | 0.01% | 0.0% |
| Q2 2018 | $66,000 | +3.1% | 1,638 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $64,000 | +10.3% | 1,638 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $58,000 | -23.7% | 1,638 | -12.2% | 0.00% | -33.3% |
| Q3 2017 | $76,000 | -5.0% | 1,865 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $80,000 | +9.6% | 1,865 | +7.9% | 0.01% | +16.7% |
| Q1 2017 | $73,000 | +4.3% | 1,728 | -5.5% | 0.01% | 0.0% |
| Q4 2016 | $70,000 | -30.0% | 1,828 | -21.3% | 0.01% | -40.0% |
| Q3 2016 | $100,000 | -5.7% | 2,323 | -5.1% | 0.01% | -16.7% |
| Q2 2016 | $106,000 | -34.6% | 2,448 | -38.6% | 0.01% | -36.8% |
| Q1 2016 | $162,000 | +16.5% | 3,988 | +15.7% | 0.02% | +11.8% |
| Q4 2015 | $139,000 | -18.7% | 3,448 | -22.5% | 0.02% | -26.1% |
| Q3 2015 | $171,000 | -7.6% | 4,448 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $185,000 | -9.8% | 4,448 | 0.0% | 0.02% | -11.5% |
| Q1 2015 | $205,000 | +6.8% | 4,448 | -1.1% | 0.03% | +8.3% |
| Q4 2014 | $192,000 | +19.3% | 4,498 | +28.6% | 0.02% | +14.3% |
| Q3 2014 | $161,000 | +27.8% | 3,498 | +48.2% | 0.02% | +23.5% |
| Q2 2014 | $126,000 | 0.0% | 2,360 | 0.0% | 0.02% | -5.6% |
| Q1 2014 | $126,000 | 0.0% | 2,360 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $126,000 | +1.6% | 2,360 | -4.8% | 0.02% | -10.0% |
| Q3 2013 | $124,000 | -17.9% | 2,480 | -18.0% | 0.02% | -13.0% |
| Q2 2013 | $151,000 | – | 3,025 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |